These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9400851)
1. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. Fox NC; Freeborough PA J Magn Reson Imaging; 1997; 7(6):1069-75. PubMed ID: 9400851 [TBL] [Abstract][Full Text] [Related]
2. Rates of cerebral atrophy differ in different degenerative pathologies. Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250 [TBL] [Abstract][Full Text] [Related]
3. Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Schott JM; Price SL; Frost C; Whitwell JL; Rossor MN; Fox NC Neurology; 2005 Jul; 65(1):119-24. PubMed ID: 16009896 [TBL] [Abstract][Full Text] [Related]
4. Gray matter atrophy rate as a marker of disease progression in AD. Anderson VM; Schott JM; Bartlett JW; Leung KK; Miller DH; Fox NC Neurobiol Aging; 2012 Jul; 33(7):1194-202. PubMed ID: 21163551 [TBL] [Abstract][Full Text] [Related]
5. Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease. Bradley KM; Bydder GM; Budge MM; Hajnal JV; White SJ; Ripley BD; Smith AD Br J Radiol; 2002 Jun; 75(894):506-13. PubMed ID: 12124237 [TBL] [Abstract][Full Text] [Related]
6. Common MRI acquisition non-idealities significantly impact the output of the boundary shift integral method of measuring brain atrophy on serial MRI. Preboske GM; Gunter JL; Ward CP; Jack CR Neuroimage; 2006 May; 30(4):1196-202. PubMed ID: 16380273 [TBL] [Abstract][Full Text] [Related]
7. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Fox NC; Cousens S; Scahill R; Harvey RJ; Rossor MN Arch Neurol; 2000 Mar; 57(3):339-44. PubMed ID: 10714659 [TBL] [Abstract][Full Text] [Related]
9. Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection. Leung KK; Clarkson MJ; Bartlett JW; Clegg S; Jack CR; Weiner MW; Fox NC; Ourselin S; Neuroimage; 2010 Apr; 50(2):516-23. PubMed ID: 20034579 [TBL] [Abstract][Full Text] [Related]
10. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Ridha BH; Barnes J; Bartlett JW; Godbolt A; Pepple T; Rossor MN; Fox NC Lancet Neurol; 2006 Oct; 5(10):828-34. PubMed ID: 16987729 [TBL] [Abstract][Full Text] [Related]
11. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study. Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778 [TBL] [Abstract][Full Text] [Related]
12. Automated hippocampal segmentation by regional fluid registration of serial MRI: validation and application in Alzheimer's disease. Crum WR; Scahill RI; Fox NC Neuroimage; 2001 May; 13(5):847-55. PubMed ID: 11304081 [TBL] [Abstract][Full Text] [Related]
13. Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials. Schott JM; Frost C; Whitwell JL; Macmanus DG; Boyes RG; Rossor MN; Fox NC J Neurol; 2006 Sep; 253(9):1147-53. PubMed ID: 16998650 [TBL] [Abstract][Full Text] [Related]
14. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. Freeborough PA; Fox NC IEEE Trans Med Imaging; 1997 Oct; 16(5):623-9. PubMed ID: 9368118 [TBL] [Abstract][Full Text] [Related]
15. Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging. Fujishima M; Kawaguchi A; Maikusa N; Kuwano R; Iwatsubo T; Matsuda H; ; J Alzheimers Dis; 2017; 56(1):75-88. PubMed ID: 27911297 [TBL] [Abstract][Full Text] [Related]
16. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease. Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108 [TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. Alavi A; Newberg AB; Souder E; Berlin JA J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease. Tarawneh R; Head D; Allison S; Buckles V; Fagan AM; Ladenson JH; Morris JC; Holtzman DM JAMA Neurol; 2015 Jun; 72(6):656-65. PubMed ID: 25867677 [TBL] [Abstract][Full Text] [Related]
19. Disease-specific patterns of cortical and subcortical degeneration in a longitudinal study of Alzheimer's disease and behavioural-variant frontotemporal dementia. Landin-Romero R; Kumfor F; Leyton CE; Irish M; Hodges JR; Piguet O Neuroimage; 2017 May; 151():72-80. PubMed ID: 27012504 [TBL] [Abstract][Full Text] [Related]
20. MRI and CSF studies in the early diagnosis of Alzheimer's disease. de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]